ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 870

Contemporary Prevalence Estimates for Giant Cell Arteritis and Polymyalgia Rheumatica, 2015

Cynthia S. Crowson1 and Eric L. Matteson2, 1Health Sciences Research, Mayo Clinic, Rochester, MN, 2Rheumatology, Mayo Clinic, Rochester, MN

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Epidemiologic methods, giant cell arteritis and polymyalgia rheumatica

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2016

Title: Vasculitis - Poster I: Large Vessel Vasculitis and Polymyalgia Rheumatica

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:   There are no estimates of the prevalence of giant cell arteritis (GCA) or polymyalgia rheumatic (PMR) in a United States population in the current millennium. The purpose of this work was to estimate the 2015 point prevalence of GCA and PMR in a population-based study performed in a US population.

Methods:   Study populations of incident cases of GCA in 1950-2009 and incidence cases of PMR in 1970-2014 were previously identified among residents of a well-characterized geographically defined area. Prevalence estimates were obtained from the incidence rates assuming no increased mortality associated with GCA or PMR, which has been previously shown, and assuming migration in and out of the geographically defined area was independent of disease status. Age, sex and calendar year specific indigence rates and population lifetables were used to derive prevalence estimates. Prevalence estimates were age- and sex-adjusted to US white 2010 population aged ≥50 years. Bootstrap sampling was used to obtain 95% confidence intervals [CI] for the prevalence estimates.

Results:   A total of 248 incident cases of GCA were diagnosed in 1950-2009 and 790 cases of PMR were diagnosed in 1970-2014. The overall age and sex adjusted prevalence rate of GCA on January 1, 2015 was 204 (95% CI: 161, 254) per 100,000 population aged 50 years and older. The prevalence rate of GCA among women was 304 (95% CI: 229, 375) per 100,000 population aged 50 years and older and among men was 91 (95% CI: 46, 156) per 100,000 population aged 50 years. The overall age and sex adjusted prevalence rate of PMR on January 1, 2015 was 744 (95% CI: 694, 793) per 100,000 population aged 50 years and older. The prevalence rate of GCA among women was 907 (95% CI: 824, 994) per 100,000 population aged 50 years and older and among men was 557 (95% CI: 475, 638) per 100,000 population aged 50 years.

Conclusion:   Prevalence rates of GCA and PMR in the new millennium to 2015 are similar to previously published prevalence estimates in the late 1990s. For GCA this reflects the fact that the incidence of GCA has been stable for the past 20 years. For PMR there have been slight increases in incidence of PMR in recent years, which have not yet affected the prevalence of PMR, but may lead to future increases in the prevalence of PMR. The health burden of these diseases among older persons continues to be substantial and reflects the need for continued efforts to better manage it.


Disclosure: C. S. Crowson, None; E. L. Matteson, None.

To cite this abstract in AMA style:

Crowson CS, Matteson EL. Contemporary Prevalence Estimates for Giant Cell Arteritis and Polymyalgia Rheumatica, 2015 [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/contemporary-prevalence-estimates-for-giant-cell-arteritis-and-polymyalgia-rheumatica-2015/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/contemporary-prevalence-estimates-for-giant-cell-arteritis-and-polymyalgia-rheumatica-2015/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology